Pandemic will accelerate AI adoption, healthcare leaders predict

In a survey of hundreds of healthcare decision-makers, Intel found that the percentage of respondents whose company is currently – or will be – using artificial intelligence nearly doubled after the onset of COVID-19. Among the predicted use cases for AI: early intervention analytics, clinical decision support and specialist collaboration. "Artificial intelligence in health and life sciences has greatly accelerated," said Stacey Shulman, vice president of the Internet of Things Group at Intel, in a blog post accompanying the findings. "From helping clinicians develop personalized protocols to streamlining clinical workloads or unlocking insights in genomics, infusing AI into these industries may be much closer than many initially thought," she said. Intel conducted an online survey of 200 senior decision-makers at healthcare organizations in April 2018, and then 230 in July 2020.